Structured evidence table for Rice Bran Cholesterol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Rice Bran Cholesterol Randomized Trial | Consuming these types can enhance the intake of antioxidants and other vital nutrients, hence promoting improved overall health and wellbeing (). | 3 | Javed Mavra (2025) | Black rice as the emerging functional food: bioactive compounds, therapeutic potential and industrial applications |
| Rice Bran Cholesterol Randomized Trial | Online sales channels increased from 12% of market volumes in 2021 to 22% in 2023, and retail penetration reached 33 countries by late 2023. | 3 | Javed Mavra (2025) | Black rice as the emerging functional food: bioactive compounds, therapeutic potential and industrial applications |
| Rice Bran Cholesterol Randomized Trial | The rise is associated with enhanced glucometabolic regulation and neurocognitive benefits, including improved memory and mood, noted in animal studies and limited human cohorts () (). | 3 | Javed Mavra (2025) | Black rice as the emerging functional food: bioactive compounds, therapeutic potential and industrial applications |
| Rice Bran Cholesterol Randomized Trial | Oryza sativa Oryza sativa 1 2 3 4 5 6 7 8 9 10 11 12 Approximately 50% of the global population relies on rice (L.) as a fundamental food source, serving as a primary energy provider. | 3 | Javed Mavra (2025) | Black rice as the emerging functional food: bioactive compounds, therapeutic potential and industrial applications |
| Rice Bran Cholesterol Randomized Trial | PURPOSE: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing public health concern in Asia, where dietary patterns differ significantly from those in Mediterranean regions. | 4 | Tan VMH (2026) | Development of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). |
| Rice Bran Cholesterol Randomized Trial | CONCLUSION: The AMED represents a culturally adapted, nutritionally coherent, and sensory-acceptable interpretation of the MedDiet for Asian populations. | 4 | Tan VMH (2026) | Development of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). |
| Rice Bran Cholesterol Randomized Trial | Although the Mediterranean Diet (MedDiet) is recommended for MASLD management, its adoption in Asia remains limited. | 4 | Tan VMH (2026) | Development of the Asian Mediterranean Diet and its sensory acceptability in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). |
Source documents